At TKL Research, our pharmacology and clinical units allow for the conduct of phase I-II studies in healthy and targeted patient populations. Multiple locations throughout the NY/NJ metro area have been strategically selected to provide us access to an extremely diverse patient population. Our metro area presence also gives us the opportunity to use the very knowledgeable NY/NJ medical community as Consulting Principal Investigators. Using our successful TKL Approach, we are able to complete your study from start to finish.
“We do more dermatological safety studies than any research clinic in the world.”